Morgan Stanley market-linked notes tied to EURO STOXX 50
Morgan Stanley Finance LLC is offering market-linked notes due July 5, 2030 linked to the EURO STOXX 50® Index with a $1,000 stated principal amount per note.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Morgan Stanley Finance LLC is offering market-linked notes due July 5, 2030 linked to the EURO STOXX 50® Index with a $1,000 stated principal amount per note. The notes pay no interest and at maturity will return principal plus an upside payment only if the final index level exceeds the initial level; otherwise you receive the stated principal amount.
The upside payment equals the stated principal amount multiplied by a participation rate (to be set on the pricing date and ranging from 113.25% to 118.25% in this preliminary supplement) times the underlier percent change. The estimated value on the pricing date is approximately $970.60 per note. All payments are subject to the issuer’s and guarantor’s credit risk; the notes will not be listed and may have limited secondary liquidity. Tax treatment is expected to be as contingent payment debt instruments for U.S. holders.
Insights
Notes offer leveraged upside with no coupon and issuer credit exposure.
The product links payoff to the EURO STOXX 50® closing level on the observation date and provides upside only if that closing level exceeds the initial level. The participation rate is material and will be set on the pricing date within the disclosed range of 113.25% to 118.25%.
Key dependencies include the final participation rate, the observation-date closing level on July 1, 2030, and Morgan Stanley’s credit spreads. Pricing and estimated value ($970.60) reflect issuance costs and hedging assumptions disclosed here; secondary market values may differ materially.
U.S. holders should expect CPDI tax treatment and annual interest accruals.
The issuer intends to treat the securities as contingent payment debt instruments for U.S. federal income tax purposes, requiring holders to accrue imputed interest each year at a comparable yield determined by the issuer. Any gain on disposition is generally ordinary interest to the extent of prior inclusions.
Non-U.S. holders should note the issuer's determination regarding Section 871(m) and that the IRS could disagree; final pricing supplement will provide the comparable yield and projected payment schedule.
Key Figures
Key Terms
Contingent Payment Debt Instrument tax
Participation Rate financial
Observation Date financial
Calculation Agent regulatory
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What payoff does MS (Morgan Stanley) Market-Linked Note provide at maturity?
What is the participation rate range for the notes in this supplement?
How much is the estimated value on the pricing date for each note?
What credit and liquidity risks apply to these Morgan Stanley notes?
How are these notes treated for U.S. federal income tax purposes?
AI-generated analysis. How Rhea-AI works. Not financial advice.